Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 17.30
-0.27 (-1.54%)
At close: Feb 2, 2026
SHE:002603 Market Cap
SHE:002603 has a market cap or net worth of 28.9 billion as of February 2, 2026. Its market cap has increased by 9.63% in one year.
Market Cap
28.90B
Enterprise Value
26.98B
Revenue
6.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
17.30
Market Cap Chart
Since July 28, 2011, SHE:002603's market cap has increased from 18.99B to 28.90B, an increase of 52.21%. That is a compound annual growth rate of 2.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 29.35B | 2.93% |
| Dec 31, 2025 | 28.52B | 6.62% |
| Dec 31, 2024 | 26.75B | -30.60% |
| Dec 29, 2023 | 38.54B | -23.00% |
| Dec 30, 2022 | 50.05B | 52.86% |
| Dec 31, 2021 | 32.75B | 7.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong-E-E-Jiao | 32.53B |
| Humanwell Healthcare (Group) | 30.00B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 29.58B |
| Livzon Pharmaceutical Group | 28.41B |
| Chengdu Kanghong Pharmaceutical Group | 27.04B |
| Dizal (Jiangsu) Pharmaceutical | 26.45B |
| Kangmei Pharmaceutical | 26.27B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 24.84B |